On the other hand, fat-specific GSTK1 overexpression shields mice from diet-induced obesity, insulin resistance, and hepatic steatosis [32], and increased GSTK1 levels have been linked to colon cancer progression [40] and improved survival in patients with luminal B breast cancer [41]. Here, GSTK1 is linked to fatty liver disease.